Literature DB >> 10460769

Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.

N Morlet, D Minassian, J Butcher.   

Abstract

BACKGROUND: Primary treatment for suspected microbial keratitis is generally successful. Although risks such as contact lens use are well recognised as causative factors for microbial keratitis, little is known about the risk factors that influence treatment outcome. The present study evaluates the risk factors assessed at diagnosis as prognostic indicators of primary treatment failure.
METHODS: Patients were prospectively enrolled in the ofloxacin treatment trial and data concerning symptoms, treatments, past and concurrent eye disease were collected along with the measurement of corneal ulcer size at the slit lamp. All patients were scraped for microbiological investigation, and treated with either ofloxacin (0. 3%) or standard therapy of fortified cefuroxime and gentamicin drops. Treatment success was complete healing of the ulcer with zero dimensions of the epithelial defect within 2 weeks of start of treatment. The important prognostic indicators were selected by comparison among those who failed treatment, had delayed healing, or were culture positive with other patients using univariate and stratified analysis. These were then used in a Poisson model for multiple regression analysis to estimate the relative risk of the main prognostic variables.
RESULTS: Of the 118 patients enrolled in the study, 14 were identified as primary treatment failures, 17 had slow healing, and 15 indolent ulcers. There were 49 culture positive patients. The multivariate analysis identified that large culture positive ulcers in patients 60 years or older had 5.5 times the risk of primary treatment failure (p<0.001). Significant predictors of slow healing were previous ocular disease and a positive culture; significant predictors of indolent ulceration were previous ocular disease and steroid use at diagnosis; the main predictor of a culture positive result was ulcer size.
CONCLUSIONS: Elderly patients with large ulcers were more likely to be culture positive, fail primary therapy, and require surgical intervention. A positive microbial culture provided prognostic information regardless of the organism isolated. However, this information was of less value for those with small ulcers and for younger patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460769      PMCID: PMC1723169          DOI: 10.1136/bjo.83.9.1027

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis.

Authors:  D J Coster; P R Badenoch
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

2.  Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.

Authors:  J A Jacobson; N B Call; E M Kasworm; M S Dirks; R B Turner
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Factors influencing predilection and outcome in bacterial keratitis.

Authors:  O G Gudmundsson; L D Ormerod; K R Kenyon; R J Glynn; A S Baker; J Haaf; S Lubars; M B Abelson; S A Boruchoff; C S Foster
Journal:  Cornea       Date:  1989       Impact factor: 2.651

4.  0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group.

Authors:  K R Wilhelmus; R A Hyndiuk; D R Caldwell; R L Abshire; A T Folkens; L B Godio
Journal:  Arch Ophthalmol       Date:  1993-09

5.  Ultrastructural and immunohistochemical features of coronal adenomas.

Authors:  H H Brown; B J Glasgow; R Y Foos
Journal:  Am J Ophthalmol       Date:  1991-07-15       Impact factor: 5.258

6.  Demographic and predisposing factors in corneal ulceration.

Authors:  D C Musch; A Sugar; R F Meyer
Journal:  Arch Ophthalmol       Date:  1983-10

7.  Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis.

Authors:  D J Parks; D A Abrams; F A Sarfarazi; H R Katz
Journal:  Am J Ophthalmol       Date:  1993-04-15       Impact factor: 5.258

8.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.

Authors:  T P O'Brien; M G Maguire; N E Fink; E Alfonso; P McDonnell
Journal:  Arch Ophthalmol       Date:  1995-10

Review 9.  Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease.

Authors:  G A Stern; M Buttross
Journal:  Ophthalmology       Date:  1991-06       Impact factor: 12.079

10.  The importance of initial management in the treatment of severe infectious corneal ulcers.

Authors:  S D McLeod; L D LaBree; R Tayyanipour; C W Flowers; P P Lee; P J McDonnell
Journal:  Ophthalmology       Date:  1995-12       Impact factor: 12.079

View more
  22 in total

1.  Microbial keratitis: what's the preferred initial therapy? View 2: Empirical fluoroquinolone therapy is sufficient initial treatment.

Authors:  N Morlet; M Daniell
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Initial therapy for suppurative microbial keratitis in Iraq.

Authors:  Faiz Al-Shakarchi
Journal:  Br J Ophthalmol       Date:  2007-06-27       Impact factor: 4.638

3.  Genetic characterization indicates that a specific subpopulation of Pseudomonas aeruginosa is associated with keratitis infections.

Authors:  Rosalind M K Stewart; Lutz Wiehlmann; Kevin E Ashelford; Stephanie J Preston; Eliane Frimmersdorf; Barry J Campbell; Timothy J Neal; Neil Hall; Stephen Tuft; Stephen B Kaye; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

4.  The steroids for corneal ulcers trial: study design and baseline characteristics.

Authors:  Muthiah Srinivasan; Jeena Mascarenhas; Revathi Rajaraman; Meenakshi Ravindran; Prajna Lalitha; David V Glidden; Kathryn J Ray; Kevin C Hong; Catherine E Oldenburg; Salena M Lee; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2011-10-10

5.  Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.

Authors:  Scott M McClintic; Namperumalsamy V Prajna; Muthiah Srinivasan; Jeena Mascarenhas; Prajna Lalitha; Revathi Rajaraman; Catherine E Oldenburg; Kieran S O'Brien; Kathryn J Ray; Nisha R Acharya; Thomas M Lietman; Jeremy D Keenan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

6.  Microbiological findings and predisposing risk factors in corneal ulcers.

Authors:  Verena Prokosch; Zisis Gatzioufas; Solon Thanos; Tobias Stupp
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-25       Impact factor: 3.117

7.  Infective keratitis in older patients: a 4 year review, 1998-2002.

Authors:  T K H Butler; N A Spencer; C C K Chan; J Singh Gilhotra; K McClellan
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

8.  Simplifying collection of corneal specimens in cases of suspected bacterial keratitis.

Authors:  Stephen B Kaye; Prasad G Rao; Godfrey Smith; John A Scott; Sharon Hoyles; Clare E Morton; Colin Willoughby; Mark Batterbury; Graham Harvey
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital.

Authors:  Ali Al-Shehri; Sabah Jastaneiah; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2008-04-03       Impact factor: 2.031

10.  Predictors of outcome in fungal keratitis.

Authors:  N Venkatesh Prajna; T Krishnan; J Mascarenhas; M Srinivasan; C E Oldenburg; C M Toutain-Kidd; A Sy; S D McLeod; M E Zegans; N R Acharya; T M Lietman; T C Porco
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.